Literature DB >> 31431867

Predictors of Prolonged Length of Stay After Lumbar Interbody Fusion: A Multicenter Study.

Kazuyoshi Kobayashi1, Kei Ando1, Fumihiko Kato2, Tokumi Kanemura3, Koji Sato4, Yudo Hachiya5, Yuji Matsubara6, Mitsuhiro Kamiya7, Yoshihito Sakai8, Hideki Yagi9, Ryuichi Shinjo10, Naoki Ishiguro1, Shiro Imagama1.   

Abstract

STUDY
DESIGN: Retrospective analysis of a prospectively database.
OBJECTIVES: To identify factors associated with prolonged length of stay (LOS) in posterior /transforaminal lumbar interbody fusion (PLIF/TLIF).
METHODS: The subjects were patients who underwent PLIF/TLIF at 10 facilities from 2012 to 2014. A total of 1168 such patients with a mean age of 65.9 ± 12.5 years (range 18-87 years) were identified in the database. Operations were PLIF (n = 675), TLIF (n = 443), minimally invasive surgery (MIS)-PLIF (n = 22), and MIS-TLIF (n = 32). Age, gender, body mass index, ambulatory status, comorbidities, perioperative American Society of Anesthesiologists (ASA) grade, operative factors, and complications were examined. LOS was defined as the number of calendar days from the operation to hospital discharge. LOS was categorized as normal (<75th percentile) or prolonged (≥75th percentile).
RESULTS: The average LOS was 20.8 ± 9.8 days (range 7-77 days). There was a significant correlation between LOS and age (P < .05). Reoperation during hospitalization was performed in 20 cases for surgical site infection (n = 12), epidural hematoma (n = 5), and screw misplacement (n = 3). In multivariate analysis, prolonged LOS was associated with preoperative variables of age ≥70 years (odds ratio [OR] 1.87, 95% CI 1.38-2.54), and ASA class ≥III (OR 1.52, 95% CI 1.04-2.25); surgical variables of open procedures (OR 5.84, 95% CI 1.74-19.63), fused levels ≥3 (OR 5.17, 95% CI 3.17-8.43), operative time ≥300 minutes (OR 1.88, 95% CI 1.15-3.07), and estimated blood loss ≥500 mL (OR 1.71, 95% 1.07-2.75).
CONCLUSIONS: The factors identified in this study should help with obtaining informed consent, surgical planning and complication prevention to reduce health care costs associated with prolonged LOS.

Entities:  

Keywords:  length of stay; multicenter; posterior lumbar interbody fusion (PLIF); postoperative complications; transforaminal lumbar interbody fusion (TLIF)

Year:  2018        PMID: 31431867      PMCID: PMC6686383          DOI: 10.1177/2192568218800054

Source DB:  PubMed          Journal:  Global Spine J        ISSN: 2192-5682


Introduction

Instrumented posterior lumbar interbody fusion (PLIF) and transforaminal lumbar interbody fusion (TLIF) are common surgical procedures used to treat lumbar spine pathology and have favorable outcomes and low morbidity.[1] Since the initial description of the PLIF technique by Briggs and Milligan in 1944,[2] the method has evolved with development of additional options of autologous and synthetic bone grafting, advanced spinal segmental fusion techniques, innovative implants (including current use of a wide variety of interbody implants), and pedicle screw fixation for posterior instrumentation. In 1982, Harms and Rolinger[3] reported a technique via the transforaminal route for insertion of an interbody cage packed with bone graft, which is now referred to as TLIF. These advances in implants and techniques have improved the outcome of spinal fusion using PLIF/TLIF. The operations can also now be performed using mini-open or minimally invasive surgery (MIS).[4-6] MIS is increasingly being applied in spine surgery after demonstration of improved clinical outcomes and decreased perioperative morbidity. This approach is also safe and effective for treatment of lumbar pathology in elderly patients. These are important because the recent rapid aging of society has increased the number of elderly patients with progressive degenerative diseases. We perform PLIF/TLIF with pedicle screw fixation to treat degenerative lumbar disorders with segmental instability. In such cases, it is essential to decompress all involved neural elements and stabilize the affected segments. This method produces satisfactory clinical results, but is associated with surgical complications, with several reports indicating that patients who undergo lumbar arthrodesis have substantially higher complication rates than those who undergo decompression alone.[7,8] Demands for spinal fusion procedures have increased as a result of the rising elderly population and morbidity associated with open fusion procedures, including substantial blood loss, increased complication rate, and longer hospital stays, may expose this patient population to undesirable surgical risks.[9-14] Length of stay (LOS) of any surgical patient is mainly a function of patient characteristics (such as age and comorbid conditions), procedure complexity, and postoperative complications or adverse events. Prolonged LOS is also associated with an increased risk of complications and morbidities after surgery, and such complications or severely ill patients increase hospital resource utilization and worsen outcomes.[15-18] Prolonged LOS is also associated with increasing costs for patients and hospitals.[16,17] Previous studies of increased LOS after spine surgery have identified associations with morbid obesity, metabolic syndrome, open versus minimally invasive surgery, age, chronic obstructive pulmonary disease (COPD), use of antidepressants, unemployment, chronic renal disease, and intraoperative fluid volume.[19-24] However, these have generally been small studies that examined isolated factors, leaving significant room for the effects of confounding variables. In this study, we examined prolonged LOS in PLIF/TLIF in a multicenter study, to identify pre-, intra-, and postoperative factors that are independently associated with prolonged LOS in a multivariate model. This approach may allow modifiable risk factors to be optimized preoperatively, while non-modifiable factors can be used for postoperative management. This information may also be useful for obtaining preoperative informed consent and for inpatient discharge planning.

Materials and Methods

Demographic Data

The study was performed as a retrospective analysis of patients who underwent PLIF/TLIF at 10 facilities from January 2012 to December 2014, using data from a prospectively maintained database. A total of 1168 patients were identified, including 602 males and 566 females. The main indications for the procedure were spondylolisthesis (n = 471), lumbar canal stenosis (n = 449), disc herniation (n = 162), adjacent segment degeneration (ASD; n = 39), and others (n = 47). Previous spinal surgery had been performed in 58 patients. Age ranged from 18 to 87 years, with a mean of 65.9 ± 12.5 years. The age distribution is shown in Figure 1 and the patient characteristics are listed in Table 1. The operations were PLIF (n = 675), TLIF (n = 443), MIS-PLIF (n = 22), and MIS-TLIF (n = 32). The mean operative time was 192.1 ± 90.8 minutes, mean estimated blood loss (EBL) was 481.3 ± 641.9 mL, and the mean range of fusion was 1.3 vertebra with instrumentation. Reoperation was performed in 20 cases. Age, gender, body mass index (BMI), ambulatory status, previous surgery, instrumented level, major medical comorbidities (hypertension, smoking status, diabetes mellitus, heart disease, pulmonary disease, renal disease, depression, anxiety, nonspinal malignancy), perioperative American Society of Anesthesiologists (ASA) grade, operative factors (procedures, number of levels fused, EBL, operative time, reoperation, use of colloids, use of a surgical drain, and LOS), and complications (dural tear, surgical site infection [SSI], pneumonia, deep vein thrombosis, epidural hematoma, and screw misplacement) were examined. The study was approved by our institutional review board (IRB No. 354-3).
Figure 1.

Age distribution (n = 1168).

Table 1.

Patient Demographics (n = 1168).

Characteristicn (%)
Age (years)
 18-3946 (3.9)
 40-4971 (6.1)
 50-59128 (10.9)
 60-69339 (29.0)
 70-79501 (42.9)
 ≥8083 (7.1)
Sex
 Female566 (48.5)
Body mass index (kg/m2)
 <1820 (1.7)
 18-22232 (19.9)
 22-25510 (43.7)
 25-30337 (28.9)
 >3069 (5.9)
Ambulation
 Independent873 (74.7)
 Need assistance272 (23.3)
 Wheelchair23 (2.0)
American Society of Anesthesiologists grade
 I521 (44.6)
 II587 (50.2)
 III55 (4.7)
 IV5 (0.4)
Comorbidities
 Hypertension449 (38.3)
 Smoker227 (19.4)
 Diabetes mellitus165 (14.1)
 Heart disease130 (11.1)
 Pulmonary disease54 (4.6)
 Renal comorbidities26 (2.2)
 Depression26 (2.2)
 Anxiety31 (2.6)
 Nonspinal malignancy52 (4.4)
Main indications
 Spondylolisthesis471 (40.3)
 Lumbar spinal stenosis,449 (38.4)
 Disc herniation162 (13.9)
 Adjacent segment degeneration39 (3.3)
 Others47 (4.0)
Previous spinal surgery58 (5.0)
Age distribution (n = 1168). Patient Demographics (n = 1168).

Length of Stay

The primary clinical outcome was LOS, which was defined as the number of calendar days from the operation to hospital discharge. Patients were categorized as having a normal LOS (<75th percentile LOS) or prolonged LOS (≥75th percentile LOS).[18] For multivariate analysis, LOS was treated as a continuous variable and the magnitude of the effect of each predictor variable on LOS was determined.

Surgical Technique

Surgical procedures were performed using similar techniques at each hospital. All institutions have multiple spine surgeons, and the details of surgery were determined by spine surgeons who were certified by the Japanese Spine Surgery and Related Research (JSSR) society at each facility. The patient was initially positioned in a prone position. In PLIF, an open midline approach with bilateral muscle strip dissection was used to access the posterior column of the vertebral body. Once the spinous process and laminae at appropriate levels were identified, laminotomy was performed medial to the facet. Titanium pedicle screws and rods were used for fixation of degenerative instability. Disc and cartilaginous endplates were removed to prepare the graft bed, and local bone morcelized by bone milling with cages was implanted in the anterior and lateral regions of the interbody space. TLIF differed from PLIF in that the spinal canal was entered via unilateral laminectomy and inferior facetectomy, which facilitates bone graft placement. A single unilateral incision was made for bilateral anterior column support and exposure of the disc space while minimizing retraction of the dural sac and nerve root. In MIS, use of percutaneous pedicle screws combined with a tubular retractor system permits performance of minimally invasive PLIF. A surgical drain was used in all cases. Among the 10 facilities in our group, 2 use the MIS strategy.

Data Analysis

Differences between 2 groups were analyzed by Mann-Whitney U test or Student t test. Univariate and multiple logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for prolonged LOS, using preoperative and perioperative variables. Cutoff values for variables (with an explanation of the derivation of the cutoff in parentheses) were defined as follows. Age 70 years (based on the median age of 69.5 years), BMI 25 and 30 kg/m2 (definitions of overweight and obese, respectively), ASA class ≥III, fused levels 2 and 3, operative time 240 and 300 minutes (chosen for examination as times that were both longer than the average operation time of 192 minutes), and EBL 500 mL (based on the average EBL of 481 mL). A Pearson correlation coefficient was calculated for the correlation between LOS and age. All analyses were conducted using SPSS version 22 for Windows (IBM, Armonk, NY). P < .05 was considered to be significant in all analyses.

Results

The demographics, comorbidities, and disease background of the patients are shown in Table 1 and surgical variables are given in Table 2. The main comorbidities were hypertension (n = 449), smoker (n = 227), diabetes mellitus (n = 165), and heart disease (n = 130) (Table 1). Perioperative and postoperative complications were dural tear (n = 50), SSI (n = 27), urinary tract infection (n = 16), pneumonia (n = 11), deep vein thrombosis (n = 10), epidural hematoma (n = 9), and screw misplacement (n = 3) (Table 2). The average LOS was 20.8 ± 9.8 days (range 7-77 days) (Figure 2), and LOS was significantly correlated with age (P < .05) (Figure 3). Reoperation during hospitalization was performed in 20 cases, for SSI (n = 12), epidural hematoma (n = 5), and screw misplacement (n = 3).
Table 2.

Surgical Variables (n = 1168).

Variablen (%)
Procedures
 Open PLIF671 (57.4)
 Open TLIF443 (37.9)
 MIS-PLIF22 (1.9)
 MIS-TLIF32 (2.7)
Number of levels fused
 1866 (74.1)
 2209 (17.9)
 372 (6.2)
 421 (1.8)
Instrumented level
 Above L5-S1654 (56.0)
 Including L5-S1514 (44.0)
Complications
 Dural tear50 (4.3)
 Surgical site infection27 (2.3)
 Urinary tract infection16 (1.4)
 Pneumonia11 (0.9)
 Deep vein thrombosis10 (0.8)
 Epidural hematoma9 (0.9)
 Screw misplacement3 (0.3)
Estimated blood loss (mL), mean ± SD481.1 ± 641.6
Operative time (min), mean ± SD192.0 ± 90.7
Reoperation20 (1.7)
Use of colloids97 (8.3)
Length of stay (days), mean ± SD20.6 ± 9.8
Figure 2.

Length of stay (LOS) after posterior/transforaminal lumbar interbody fusion (PLIF/TLIF). Cases with prolonged LOS (≥75th percentile) are shown to the right of the vertical dashed line.

Figure 3.

A significant positive correlation was observed between length of stay (LOS) and age (P < .05).

Surgical Variables (n = 1168). Length of stay (LOS) after posterior/transforaminal lumbar interbody fusion (PLIF/TLIF). Cases with prolonged LOS (≥75th percentile) are shown to the right of the vertical dashed line. A significant positive correlation was observed between length of stay (LOS) and age (P < .05). The characteristics of patients with normal and prolonged LOS are shown in Table 3. Age ≥70 years (P < .01), ASA class ≥III (P < .05), diabetes mellitus (P < .01), hypertension (P < .01), cardiac comorbidities (P < .01), open procedures (P < .01), fused levels (P < .01), operative time (P < .01), EBL (P < .01), dural tear (P < .05), SSI (P < .01), deep vein thrombosis (P < .01), epidural hematoma (P < .01), and pneumonia (P < .01) were significantly related to prolonged LOS (Table 3).
Table 3.

Characteristics of Patient With Normal and Prolonged LOS After Lumbar Posterior Fixation.

VariableNormal LOSProlonged LOS P
Total (n)886282
Preoperative variables, %
 Age ≥70 years46.659.9<.01
 Female47.650.7NS
 BMI >25 kg/m234.335.8NS
 BMI >30 kg/m25.66.7NS
 Ambulation: Independent75.273.4NS
 ASA class ≥III4.68.1<.05
 Previous surgery4.95.0NS
Comorbidities variables, %
 Smoker19.618.4NS
 Diabetes mellitus11.223.0<.01
 Hypertension35.247.8<.01
 Cardiac comorbidities9.715.6<.01
 Pulmonary comorbidities4.35.3NS
 Renal comorbidities2.22.1NS
 Depression2.12.4NS
 Anxiety2.43.5NS
 Nonspinal malignancy3.76.4NS
Surgical variables, %
 Open PLIF/TLIF94.398.9<.01
 Fused levels ≥224.741.1<.01
 Fused levels ≥34.319.1<.01
 Operative time ≥240 min4.719.9<.01
 Operative time ≥300 min13.229.7<.01
 EBL ≥500 mL17.429.7<.01
 Instrumented level (above L5-S1)56.853.5NS
Complications variables, %
 Urinary tract infection1.12.2NS
 Dural tear3.66.3<.05
 Surgical site infection0.77.4<.01
 Deep vein thrombosis0.22.8<.01
 Epidural hematoma0.32.1<.01
 Pneumonia0.23.2<.01
 Screw misplacement0.20.4NS
LOS (days), mean ± SD16.5 ± 4.338.2 ± 20.9<.01

Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; EBL, estimated blood loss; LOS, length of stay; NS, nonsignificant; PLIF, posterior lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion.

Characteristics of Patient With Normal and Prolonged LOS After Lumbar Posterior Fixation. Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; EBL, estimated blood loss; LOS, length of stay; NS, nonsignificant; PLIF, posterior lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion. The results of univariate and multivariate analyses are shown in Tables 4. In multivariate logistic regression, prolonged LOS was associated with preoperative variables of age ≥70 years (OR 1.87, 95% CI 1.38-2.54) and ASA class ≥III (OR 1.52, 95% CI 1.04-2.25); surgical variables of open procedures (OR 5.84, 95% CI 1.74-19.63), fused levels ≥3 (OR 5.17, 95% CI 3.17-8.43), operative time ≥300 minutes (OR 1.88, 95% CI 1.15-3.07), and EBL ≥500 mL (OR 1.71, 95% CI 1.07-2.75) (Table 4).
Table 4.

Univariate and Multivariate Logistic Regression Analysis for Prolonged Length of Stay.

VariableUnivariateMultivariate
OR (95% CI) P OR (95% CI) P
Preoperative variables
 Age ≥70 years2.58 (1.37-5.82)<.011.87 (1.38-2.54)<.01
 ASA class ≥III2.41 (1.42-5.24)<.051.52 (1.04-2.25)<.05
 Diabetes mellitus1.42 (1.24-2.78)<.01
 Hypertension1.84 (1.04-3.26)<.01
 Cardiac comorbidities1.32 (1.09-2.45)<.01
Perioperative variables
 Open PLIF/TLIF, %8.82 (2.17-23.12)<.015.84 (1.74-19.63)<.01
 Fused levels ≥2, %2.13 (1.37-3.97)<.01
 Fused levels ≥3, %6.88 (2.41-12.43)<.015.17 (3.17-8.43)<.01
 Operative time ≥240 min, %1.75 (1.15-3.75)<.01
 Operative time ≥300 min, %2.74 (1.35-4.64)<.011.88 (1.15-3.07)<.05
 Estimated blood loss ≥500 mL, %2.36 (1.32-3.95)<.011.71 (1.07-2.75)<.05
 Dural tear1.89 (1.06-4.21)<.05

Abbreviations: ASA, American Society of Anesthesiologists; CI, confidence interval; OR, odds ratio adjusted for age; PLIF, posterior lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion.

Univariate and Multivariate Logistic Regression Analysis for Prolonged Length of Stay. Abbreviations: ASA, American Society of Anesthesiologists; CI, confidence interval; OR, odds ratio adjusted for age; PLIF, posterior lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion.

Discussion

More efficient functional recovery from surgery and capacity improvement are required in hospitals in Japan. A prolonged LOS is likely to increase health care expenditures, and surgeons and providers are constantly seeking ways to improve cost-effectiveness while maintaining or improving outcomes in an era of rising health care costs.[25] Shortening the number of hospital days is required by medical system reform, and further expediting discharge will lead to a reduction in medical costs. Hospital LOS is important to patients and providers, and this study was thus designed to determine factors that affect LOS after PLIF/TLIF and the relative effects of each factor on LOS. Multivariate analysis was performed on preoperative and intraoperative variables in 1168 patients to identify factors affecting LOS that can be used for preoperative informed consent to patient and postoperative management. Similar analyses have been used to identify factors affecting LOS after revision lumbar fusion[26] and one-level minimally invasive posterior lumbar interbody fusion and instrumentation.[27] These studies showed that age, number of fused levels, fluid balance, narcotic use, and preoperative hemoglobin, among other variables, affect LOS. However, to our knowledge, factors associated with prolonged LOS after PLIF/TLIF, including both open and MIS procedures, have not been determined. Preoperative age and ASA class ≥III were significant predictors of prolonged LOS in our cohort, but comorbidities such as diabetes mellitus, hypertension, and pulmonary disease were not significantly associated with LOS. Thus, the ASA class serves as a general risk factor, while specific comorbidities may already have been treated by the time of surgery. This shows the importance of ASA assessment of the general condition just before surgery. The ASA class is used by anesthesiologists to assess preoperative risk in patients undergoing surgery.[28] Our results show that an ASA class ≥III can be used to identify patients with a probable prolonged LOS after elective posterior lumbar fusion. The ASA class takes into account patient comorbidities, but it is of note that this class was independently associated with prolonged LOS. Open surgical procedures, operative time ≥300 minutes, EBL ≥500 mL, and number of fused levels were also significantly associated with prolonged LOS. An increased operative time is generally associated with a more complex case, a greater risk of intraoperative complications, and increased EBL. Multilevel procedures may also be associated with increased operative time and EBL; however, all of these factors were found to be independent predictors with low collinearity in the final multivariate model. The rate of use of MIS is increasing in Japan. Since the first description of minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in 2003,[29] MIS approaches to lumbar spine fusion have been widely adopted. Previous reports have shown shorter hospitalization in patients undergoing MIS procedures, with decreases in LOS ranging from 15.0% to 64.0%.[30-34] Our results are consistent with these findings. We note that the percentage of procedures performed using MIS in this study is relatively low and lower than the national average, despite the study being performed at multiple centers. This is because most of our facilities still perform open surgery. The aging of society in Japan has resulted in an increase in the age of patients, and 7.1% of the patients in our cohort were older than 80 years. We have previously reported that an elderly age is a risk factor for postoperative complications in spine surgery.[12- 14] In the current series, complications of SSI, deep vein thrombosis, epidural hematoma, and pneumonia had significant effects on LOS. These are all major life-threatening complications, and particular care is required regarding the surgical indication and procedure for very elderly patients to prevent such complications. A prolonged LOS was associated with increased health care costs for admission in this cohort, as found in a previous study.[35] This emphasizes the value of predicting readmission risk as a cost-containment measure. Furthermore, the average LOS in our cohort was 20.8 days, which was longer than the average LOS after spinal surgery of 3.9 to 18.5 days found in several previous studies.[26,27,36,37] In our series, many patients had a good wound state after bathing allowed confirmation of the wound condition, but most were not discharged to home until their walking level was satisfactory. That is, the time point at which gait stabilized was often used as a criterion for discharge. Furthermore, all patients in Japan have public insurance, and this system uses a fixed payment system that is evaluated based on the Diagnosis Procedure Combination. Thus, it is possible for a patient to reduce their personal hospital fees using public insurance, even in long-term hospitalization. These factors may explain the longer LOS in our study compared to that in other countries, and these features may be peculiar to Japan. The study has several limitations. First, a number of factors were not captured in tracking of hospital LOS, including socioeconomic factors and availability of staff for discharge. For example, prolonged LOS might result from a patient being unable to obtain personal transportation home, despite being ready for discharge. Second, even without complications, poorly controlled pain is a major reason why patients tend to stay in hospital for longer than the expected time, but we did not collect data for pain. Third, we could not collect details for the amount of crystalloids administered, the time the patient spent in the operating room, and use of cell salvage. However, we investigated age, gender, BMI, ambulatory status, comorbidities, perioperative ASA grade, operative factors, and complications in 1168 cases of PLIF/TLIF, and this detailed data make this report of value for examining risk factors for prolonged LOS.

Conclusions

A multivariate analysis of a prospectively maintained database identified age ≥70 years, ASA class ≥III, open surgery, fused levels ≥3, operative time ≥300 minutes, and EBL ≥500 mL as significant predictors of prolonged LOS in a large multicenter cohort that underwent PLIF/TLIF. These risk factors can be used for obtaining informed consent, surgical planning, and complication prevention in patients receiving spine surgery, with the goal of reducing health care expenditures by decreasing the number of cases with prolonged LOS.
  36 in total

Review 1.  Minimally invasive lumbar fusion.

Authors:  Kevin T Foley; Langston T Holly; James D Schwender
Journal:  Spine (Phila Pa 1976)       Date:  2003-08-01       Impact factor: 3.468

2.  Infection of the surgical site after arthroplasty of the hip.

Authors:  S Ridgeway; J Wilson; A Charlet; G Kafatos; A Pearson; R Coello
Journal:  J Bone Joint Surg Br       Date:  2005-06

Review 3.  Minimally invasive lumbar spinal fusion.

Authors:  Jason C Eck; Scott Hodges; S Craig Humphreys
Journal:  J Am Acad Orthop Surg       Date:  2007-06       Impact factor: 3.020

4.  Surgical versus nonsurgical therapy for lumbar spinal stenosis.

Authors:  James N Weinstein; Tor D Tosteson; Jon D Lurie; Anna N A Tosteson; Emily Blood; Brett Hanscom; Harry Herkowitz; Frank Cammisa; Todd Albert; Scott D Boden; Alan Hilibrand; Harley Goldberg; Sigurd Berven; Howard An
Journal:  N Engl J Med       Date:  2008-02-21       Impact factor: 91.245

5.  Perioperative complications and adverse events after lumbar spinal surgery: evaluation of 1012 operations at a single center.

Authors:  Shiro Imagama; Noriaki Kawakami; Taichi Tsuji; Tetsuya Ohara; Yuji Matsubara; Tokumi Kanemura; Manabu Goto; Yoshito Katayama; Naoki Ishiguro
Journal:  J Orthop Sci       Date:  2011-07-02       Impact factor: 1.601

6.  Factors predicting hospital stay, operative time, blood loss, and transfusion in patients undergoing revision posterior lumbar spine decompression, fusion, and segmental instrumentation.

Authors:  Fengyu Zheng; Frank P Cammisa; Harvinder S Sandhu; Federico P Girardi; Safdar N Khan
Journal:  Spine (Phila Pa 1976)       Date:  2002-04-15       Impact factor: 3.468

7.  Complications in posterior fusion and instrumentation for degenerative lumbar scoliosis.

Authors:  Kyu-Jung Cho; Se-Il Suk; Seung-Rim Park; Jin-Hyok Kim; Sung-Soo Kim; Won-Kee Choi; Kang-Yoon Lee; Seung-Ryol Lee
Journal:  Spine (Phila Pa 1976)       Date:  2007-09-15       Impact factor: 3.468

8.  The impact of chronic obstructive pulmonary disease and obesity on length of stay and cost of spine surgery.

Authors:  M Sami Walid; Nadezhda V Zaytseva
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

9.  Expenditures and health status among adults with back and neck problems.

Authors:  Brook I Martin; Richard A Deyo; Sohail K Mirza; Judith A Turner; Bryan A Comstock; William Hollingworth; Sean D Sullivan
Journal:  JAMA       Date:  2008-02-13       Impact factor: 56.272

10.  American Society of Anaesthesiologists physical status classification.

Authors:  Mohamed Daabiss
Journal:  Indian J Anaesth       Date:  2011-03
View more
  5 in total

1.  Biportal Endoscopic Technique for Transforaminal Lumbar Interbody Fusion: Review of Current Research.

Authors:  Min-Seok Kang; Dong Hwa Heo; Hyoung-Bok Kim; Heung-Tae Chung
Journal:  Int J Spine Surg       Date:  2021-12

2.  Variations in LOS and its main determinants overtime at an academic spinal care center from 2006-2019.

Authors:  Dandurand Charlotte; N Hindi Mathew; Ailon Tamir; Boyd Michael; Charest-Morin Raphaële; Dea Nicolas; Dvorak Marcel; Fisher Charles; K Kwon Brian; Paquette Scott; Street John
Journal:  Eur Spine J       Date:  2022-01-11       Impact factor: 2.721

3.  Trends in the numbers of spine surgeries and spine surgeons over the past 15 years.

Authors:  Kazuyoshi Kobayashi; Koji Sato; Fumihiko Kato; Tokumi Kanemura; Hisatake Yoshihara; Yoshihito Sakai; Ryuichi Shinjo; Tetsuya Ohara; Hideki Yagi; Yuji Matsubara; Kei Ando; Hiroaki Nakashima; Shiro Imagama
Journal:  Nagoya J Med Sci       Date:  2022-02       Impact factor: 1.131

4.  Performance of Artificial Intelligence-Based Algorithms to Predict Prolonged Length of Stay after Lumbar Decompression Surgery.

Authors:  Babak Saravi; Alisia Zink; Sara Ülkümen; Sebastien Couillard-Despres; Frank Hassel; Gernot Lang
Journal:  J Clin Med       Date:  2022-07-13       Impact factor: 4.964

5.  Influence of Preoperative Handgrip Strength on Length of Stay after Lumbar Fusion Surgery.

Authors:  Seo Hee Ko; Sang Jun Park; Na Young Kim; Woohyuk Jeon; Dong Ah Shin; Shin Hyung Kim
Journal:  J Clin Med       Date:  2022-07-06       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.